Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning approach to analyzing complex care coordination patterns for medically complex children.

BMC medical informatics and decision making·2026
Same author

Sustained efficacy and long-term outcomes of autologous oral mucosal epithelial cell sheet transplantation for pediatric esophageal anastomotic restenosis.

Scientific reports·2026
Same author

The Expression of Placental 17β-Hydroxysteroid Dehydrogenase Genes Is Associated with the Elevation of Active Androgens and Estrogens in Pregnant Women, but Does Not Affect 11-Oxygenated C19 Steroids.

International journal of molecular sciences·2026
Same author

In-utero cell transplantation for hypophosphatasia with gene-edited hESC-derived MSCs in a murine model.

Molecular therapy. Advances·2026
Same author

The feasibility of human embryonic stem cell (hESC)-derived cartilage for tracheoplasty.

Regenerative therapy·2025
Same author

Generation of implant-type tissue-engineered cartilage from human embryonic stem cell-derived chondrocytes.

Regenerative therapy·2025

Related Experiment Video

Updated: Jun 2, 2026

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

Induced pluripotent stem cells as a next-generation biomedical interface.

Katherine E Hankowski1, Takashi Hamazaki, Akihiro Umezawa

  • 1Department of Pathology, Center for Cellular Reprogramming, University of Florida College of Medicine, Gainesville, 32610, USA.

Laboratory Investigation; a Journal of Technical Methods and Pathology
|May 11, 2011
PubMed
Summary

Induced pluripotent stem cells (iPSCs) offer a powerful experimental interface to study disease mechanisms and genetic links identified through genome-wide association studies (GWAS). These patient-specific cells accelerate drug discovery and enable personalized medicine by predicting treatment efficacy and toxicity.

More Related Videos

Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells
04:23

Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells

Published on: March 31, 2021

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension
04:48

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Published on: March 1, 2024

Related Experiment Videos

Last Updated: Jun 2, 2026

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells
04:23

Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells

Published on: March 31, 2021

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension
04:48

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Published on: March 1, 2024

Area of Science:

  • Genomics
  • Stem Cell Biology
  • Translational Medicine

Background:

  • Advances in DNA sequencing and genome-wide association studies (GWAS) are rapidly expanding our understanding of genetic links to human diseases.
  • Discovering genetic linkages is crucial, but experimental models are needed to elucidate the pathobiological mechanisms of polygenic diseases.
  • Induced pluripotent stem cells (iPSCs) retain patient-specific genetic information, offering a promising resource for disease research.

Purpose of the Study:

  • To review the potential of patient-specific iPSCs as a biomedical interface for clinical translational research.
  • To highlight the utility of iPSCs in understanding disease mechanisms and facilitating drug discovery.
  • To discuss the role of iPSCs in advancing personalized medicine through predicting drug efficacy and toxicity.

Main Methods:

  • Review of existing literature on iPSC applications in disease research.
  • Discussion of how iPSCs recapitulate disease phenotypes in vitro.
  • Integration of GWAS data with iPSC technology for predictive applications.

Main Results:

  • Disease-specific iPSCs have demonstrated utility in understanding disease mechanisms.
  • iPSC-derived cells can serve as a rapid screening tool for drug discovery by recapitulating disease phenotypes.
  • Combining GWAS information with iPSCs can predict individual drug efficacy and toxicity.

Conclusions:

  • Patient-specific iPSCs represent a powerful tool for bridging genetic discoveries with clinical applications.
  • iPSCs are essential for elucidating the pathobiology of complex genetic diseases.
  • The integration of iPSCs and GWAS data is pivotal for advancing personalized medicine and clinical translational research.